| Combenefit: An interactive platform for the analysis and visualisation of drug combina- tions DIJ Giovanni Y. Di Veroli, Chiara Fornari, Dennis Wang, Séverine Mollard, Jo ... Bioinformatics, 2016 | 597 | 2016 |
| Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing mice N Hartung, S Mollard, D Barbolosi, A Benabdallah, G Chapuisat, G Henry, ... Cancer research 74 (22), 6397-6407, 2014 | 120 | 2014 |
| Amine− guanidine switch: A promising approach to improve DNA binding and antiproliferative activities K Ohara, M Smietana, A Restouin, S Mollard, JP Borg, Y Collette, ... Journal of medicinal chemistry 50 (26), 6465-6475, 2007 | 71 | 2007 |
| How can grafted breast cancer models be optimized? S Mollard, Y Mousseau, Y Baaj, L Richard, J Cook-Moreau, J Monteil, ... Cancer biology & therapy 12 (10), 855-864, 2011 | 43 | 2011 |
| In vitro 3D angiogenesis assay in egg white matrix: comparison to Matrigel, compatibility to various species, and suitability for drug testing Y Mousseau, S Mollard, H Qiu, L Richard, R Cazal, A Nizou, N Vedrenne, ... Laboratory investigation 94 (3), 340-349, 2014 | 38 | 2014 |
| Model driven optimization of antiangiogenics+ cytotoxics combination: application to breast cancer mice treated with bevacizumab+ paclitaxel doublet leads to reduced tumor … S Mollard, J Ciccolini, DC Imbs, R El Cheikh, D Barbolosi, S Benzekry Oncotarget 8 (14), 23087, 2017 | 37 | 2017 |
| Biodistribution, tumor uptake and efficacy of 5-FU-loaded liposomes: why size matters R Fanciullino, S Mollard, F Correard, S Giacometti, C Serdjebi, A Iliadis, ... Pharmaceutical research 31, 2677-2684, 2014 | 30 | 2014 |
| Fingolimod inhibits PDGF-B-induced migration of vascular smooth muscle cell by down-regulating the S1PR1/S1PR3 pathway Y Mousseau, S Mollard, L Richard, A Nizou, K Faucher-Durand, ... Biochimie 94 (12), 2523-2531, 2012 | 30 | 2012 |
| Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model Y Mousseau, S Mollard, K Faucher-Durand, L Richard, A Nizou, ... Breast cancer research and treatment 134, 31-40, 2012 | 29 | 2012 |
| In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical Modeling S Mollard, R Fanciullino, S Giacometti, C Serdjebi, S Benzekry, J Ciccolini Scientific Reports 6 (1), 36173, 2016 | 24 | 2016 |
| In Vitro and In Vivo Evaluation of Lipofufol, a New Triple Stealth Liposomal Formulation of Modulated 5-Fu: Impact on Efficacy and Toxicity R Fanciullino, S Mollard, S Giacometti, Y Berda-Haddad, M Chefrour, ... Pharmaceutical research 30, 1281-1290, 2013 | 17 | 2013 |
| Model-based optimization of combined antiangiogenic+ cytotoxics modalities: Application to the bevacizumab-paclitaxel association in breast cancer models S Mollard, S Benzekry, S Giacometti, C Faivre, F Hubert, J Ciccolini, ... Cancer Research 74 (19_Supplement), 3677-3677, 2014 | 4 | 2014 |
| Cytidine deaminase deficiency and severe toxicities upon aza-cytidine intake: Clinical observations and experimental evidences. R Fanciullino, C Serdjebi, S Mollard, R Costello, LH Ouafik, J Ciccolini, ... Cancer Research 73 (8_Supplement), 2208-2208, 2013 | 3 | 2013 |
| Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model Breast Cancer Research and Treatment M Yoanne, S Mollard, K Faucher-Durand, L Richard, A Nizou, ... Volume 134, 31-40, 2012 | 2 | 2012 |
| Abstract B54: Genetically engineered mouse-derived allografts (GEDAs): an immunocompetent mouse model of PDAC for the evaluation of novel therapeutic strategies S Mollard, KK Frese, A Gopinathan, FM Richards, DI Jodrell Cancer Research 76 (24_Supplement), B54-B54, 2016 | 1 | 2016 |
| A new mathematical model for describing metastatic spreading: Validation in tumor-bearing mice, confrontation with clinical data and in silico simulations to optimize treatment … S Mollard, J Ciccolini, N Hartung, C Faivre, S Benzekri, G Chapuisat, ... Cancer Research 73 (8_Supplement), 402-402, 2013 | 1 | 2013 |
| Genetically engineered mouse-derived allografts (GEDAs): an immunocompetent mouse model of PDAC for the evaluation of novel therapeutic strategies S Mollard, KK Frese, A Gopinathan, FM Richards, DI Jodrell CANCER RESEARCH 76, 2016 | | 2016 |
| Benefits of Sutent/Gilenya combination in breast cancer model treatment in rats Y Mousseau, S Mollard, L Richard, Y Baaj, FG Sturtz BULLETIN DU CANCER 98, S61-S61, 2011 | | 2011 |
| Reduction of tumoral growth through local resizing of Paclitaxel and Suten via hydrogel S Mollard, Y Mousseau, L Richard, A Nizou, Y Baaj, FG Sturtz BULLETIN DU CANCER 98, S60-S61, 2011 | | 2011 |
| Relargage de chimiothérapies par un hydrogel biocompatible résorbable S Mollard Limoges, 2011 | | 2011 |
